Treatment of premenstrual dysphoric diso
β
Teri B. Pearlstein; Gloria A. Bachmann; Howard A. Zacur; Kimberly A. Yonkers
π
Article
π
2005
π
Elsevier Science
π
English
β 557 KB
## Purpose: This multicenter, double-blind, placebo-controlled crossover study evaluated the efficacy of a new oral contraceptive (oc) formulation containing drospirenone 3 mg and ethinyl estradiol (ee) 20 mug in treating symptoms of premenstrual dysphoric disorder (pmdd). ## Method: The oc formu